STTK Rasio cepet Shattuck Labs Inc

This chart illustrates the market value of Shattuck Labs, Inc. (STTK) on the GURU.Markets platform, where the indicator stands at 26.45, accompanying the development of Shattuck Labs, Inc. in the field of creating oncological proteins to combat lymphomas. The company's growth relies on ARC technology and the test results of SL-172154 in leukemia therapy. The business's success is based on the effectiveness of the GADLEN system in ensuring drug safety.

For an investor in Shattuck Labs, Inc. (STTK), which develops innovative proteins for cancer therapy, assessing financial autonomy during costly clinical trials is critical. The quick ratio, reflected in the quick liquidity history, measures the company's ability to meet short-term obligations using cash and accounts receivable without relying on inventory, confirming the resilience of the operating cycle.